Cary Street Partners Financial »

Haemonetics Corporation shares owned by Cary Street Partners Financial

Quarter-by-quarter ownership of Haemonetics Corporation (HAE) shares owned by Cary Street Partners Financial from 13F filings

Historical chart of Cary Street Partners Financial investment in Haemonetics Corporation

Tip: Access up to 7 years of quarterly data

All positions including Haemonetics Corporation held by Cary Street Partners Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Haemonetics Corporation by Cary Street Partners Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.2M 26k 48.74
2025-06-30 $1.4M 18k 74.61

More positions owned by Cary Street Partners Financial

Vanguard Value Etf Etf (VTV)
Apple Stock (AAPL)
Microsoft Corp Stock (MSFT)
Vanguard Growth Etf Etf (VUG)
Fairlead Tactical Sector ETF Etf (TACK)
Jpmorgan Equity Premium Income Etf Etf (JEPI)
Tcw Flexible Income Etf Etf (FLXR)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Jpmorgan Income Etf Etf (JPIE)
Amazon Stock (AMZN)
State Street Spdr Portfolio S&p 500 Etf Etf (SPLG)
Vanguard Small-cap Etf Etf (VB)
Jpmorgan Active Growth Etf Etf (JGRO)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)

View all positions for Cary Street Partners Financial

Top funds holding Haemonetics Corporation

BlackRock
Vanguard Group
Neuberger Berman Group
AQR Capital Management
State Street Corporation
River Road Asset Management
UBS Group
Royal Bank of Canada
FMR
Geode Capital Management
Dimensional Fund Advisors
Allspring Global Investments Holdings
T. Rowe Price Investment Management
Btim
Millennium Management

View all funds holding Haemonetics Corporation